CytoKi Pharma

Treatment of epithelial injury

CytoKi Pharma

About the company

CytoKi Pharma is a biotechnology company focused on developing novel medicines for diseases with a significant unmet medical need with focus on serious diseases caused by epithelial injury. Our lead program is based on an engineered long-acting IL-22 protein licensed from a major pharma company.

CytoKi Pharma

IL-22

Interleukin-22 is a key player in protecting and repairing tissues upon an injury. It is a unique cytokine in that it is released from immune cells but does not target immune cells. A correctly functioning immune system is essential in keeping us healthy in the multitude of challenges our organism encounters.

Lung

· Protects cells and barrier function
· Accelerates regeneration
· Strengthens mucosal immunity
· Anti-inflammation
· Anti-fibrosis

Kidney

· Protects cells
· Accelerates regeneration
· Anti-inflammation
· Anti-fibrosis

Skin

· Repair (wound healing)
· Anti-inflammation
· Angiogenesis and anti-scaring

Liver

· Protects cells
· Accelerates regeneration
· Anti-inflammation
· Anti-fibrosis

Gut

· Protects cells
· Accelerates regeneration
· Strengthens mucosal immunity
· Tight junction formation
· Anti-inflammation